Citace podle APA

Zhou, L., Mudianto, T., Ma, X., Riley, R., & Uppaluri, R. (2019). Targeting EZH2 enhances antigen presentation, antitumor immunity and circumvents anti-PD-1 resistance in head and neck cancer. Clin Cancer Res.

Styl Chicago

Zhou, Liye, Tenny Mudianto, Xiaojing Ma, Rachel Riley, a Ravindra Uppaluri. "Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer." Clin Cancer Res 2019.

Citace podle MLA

Zhou, Liye, et al. "Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer." Clin Cancer Res 2019.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..